|
China Sky One Medical,Inc.
|
 23/03/2010
[Company watch]
China Sky One to launch 13 products in six months
China Sky One Medical said that it will be launching 13 new, SFDA approved, products over the next few quarters
|
| |
|
China Sky One Medical said that it will be launching 13 new, SFDA approved, products over the next few quarters.
Since earlier SFDA approvals of these products, the company has been testing production quality and evaluating stability of the final manufacturing process in preparation for commercial production. According to the company, commercialization preparation for these 13 products is now complete or nearing completion.
The products are oxymetazoline nasal drops, moschus liniment, ftibamzone liniment, tobramycin eye drops, calcium folinate injection, sodium eye drops, aciclovir gel, antiasthma cream, naphazoline spray, skincare cream, nasal drop to treat sniffles, propylgallate injection, and dithranol ointment. The company anticipates that launching of these products will be complete in next six months starting from March 2010 to September 2010.
“We look forward to the near-term launch of several products from our R&D pipeline and are now working on the sales forecast for these products diligently. Looking ahead, we are committed to provide more transparency to the investment community about the progress of our rich R&D pipeline. We expect to continue to diversify our rich product portfolio to strengthen the company\'s competitive position and support sustainable long-term growth,” said Mr Yan-Qing Liu, Chairman and CEO of China Sky One Medical. |
|
|
|
|
